Biotech Investors & VC Firms in Belgium

55 firms in this list, with a median first check of $545K. 13 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SE Senovo ABFMMGMG6 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $5.4M	+ Add to CRM
FU Fund+ BDHNCGCB11 people	88🔒	Leuven	BE	Series A–Series B	$5.5M – $16.5M	+ Add to CRM
IN Innovation Fund sa/nv PBCVCJEC17 people	88🔒	Schaerbeek	BE	Seed–Series B	$270K – $2.7M	+ Add to CRM
TE TechVision Fund BKBLDAPB17 people · Leads rounds	88🔒	Aachen	DE	Pre-Seed–Series A	$550K – $2.2M	+ Add to CRM
NE Newton Biocapital APGTPDDM15 people · Leads rounds	88🔒	Brussels	BE	Seed–Series A	—	+ Add to CRM
NE New Rhein Healthcare Investors, LLC NGIGSSAA15 people	88🔒	Philadelphia	US	Series A–Late Stage	—	+ Add to CRM
DR Droia Ventures GGJNLDMV7 people · Follows rounds	88🔒	Leuven	BE	Pre-Seed–Series B	$540K	+ Add to CRM
HE Heran Partners AVHVJMKV12 people	88🔒	Antwerp	BE	Seed–Series B	—	+ Add to CRM
NO Novalis Biotech JVWVKMJB9 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
PA PAI Partners AAAAEAEA8 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
AE Aescap Life Sciences PKPDBJGH14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
EU Eurazeo LGLMMTNW12 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
MI Ming capital BYJ(H(L(6 people	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLCW12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM
SA Sambrinvest EDFCGGMS11 people	88🔒	Charleroi	BE	Series A–Late Stage	—	+ Add to CRM
RT RTW Investments L.P. NYGMJKLC16 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
WA Wallonie Entreprendre BLCFGLMB9 people	88🔒	Liège	BE	Pre-Seed–Late Stage	—	+ Add to CRM
VI VIVES Partners AVPDSSYV4 people	88🔒	Wavre	BE	Pre-Seed–Series B	$108K – $7.6M	+ Add to CRM
VI VIB JVCDASDE9 people · Follows rounds	88🔒	Ghent	BE	Seed–Late Stage	—	+ Add to CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
SE Seido Capital OBTRPE3 people · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	$270K – $2.7M	+ Add to CRM
AL Alpina Partners FSPS2 people · Leads rounds	88🔒	Munich	DE	Series A–Late Stage	$635K – $2.5M	+ Add to CRM
VE Vento DDITTM3 people · Follows rounds	88🔒	Torino	IT	Pre-Seed–Seed	$165K – $1.1M	+ Add to CRM
ÉP Épimède MF1 person	88🔒	Liège	BE	Seed–Series B	$1.1M – $7.6M	+ Add to CRM

Senovo

MunichSeed–Late Stage$1.1M – $5.4M

ABFMMGMG6 people

Fund+

LeuvenSeries A–Series B$5.5M – $16.5M

BDHNCGCB11 people

Innovation Fund sa/nv

SchaerbeekSeed–Series B$270K – $2.7M

PBCVCJEC17 people

TechVision Fund

AachenPre-Seed–Series A$550K – $2.2M

BKBLDAPB17 people

Newton Biocapital

BrusselsSeed–Series A

APGTPDDM15 people

New Rhein Healthcare Investors, LLC

PhiladelphiaSeries A–Late Stage

NGIGSSAA15 people

Droia Ventures

LeuvenPre-Seed–Series B$540K

GGJNLDMV7 people

Heran Partners

AntwerpSeed–Series B

AVHVJMKV12 people

Novalis Biotech

GhentPre-Seed–Series A

JVWVKMJB9 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAAAEAEA8 people

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDBJGH14 people

Eurazeo

ParisSeries A–Late Stage

LGLMMTNW12 people

Ming capital

ShenzhenSeed–Late Stage

BYJ(H(L(6 people

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLCW12 people

Sambrinvest

CharleroiSeries A–Late Stage

EDFCGGMS11 people

RTW Investments L.P.

New YorkSeed–Series A

NYGMJKLC16 people

Wallonie Entreprendre

LiègePre-Seed–Late Stage

BLCFGLMB9 people

VIVES Partners

WavrePre-Seed–Series B$108K – $7.6M

AVPDSSYV4 people

VIB

GhentSeed–Late Stage

JVCDASDE9 people

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Seido Capital

BrusselsPre-Seed–Late Stage$270K – $2.7M

OBTRPE3 people

Alpina Partners

MunichSeries A–Late Stage$635K – $2.5M

FSPS2 people

Vento

TorinoPre-Seed–Seed$165K – $1.1M

DDITTM3 people

Épimède

LiègeSeed–Series B$1.1M – $7.6M

MF1 person

Data sourced from public filings and firms' own websites — see our methodology.